Alesha J Smith
Overview
Explore the profile of Alesha J Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
MacDonald C, Murphy A, Isenor J, Ramsey T, Furlotte K, Smith A, et al.
Can Pharm J (Ott)
. 2023 Jul;
156(4):194-203.
PMID: 37435507
Background: Pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) is a highly effective way to reduce virus transmission. There have been increasing calls to improve access to PrEP in Canada....
2.
Booker C, Murphy A, Isenor J, Ramsey T, Smith A, Bishop A, et al.
Can Pharm J (Ott)
. 2023 May;
156(3):137-149.
PMID: 37201164
Background: Pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) prevention is highly effective. Pharmacists can increase PrEP accessibility through pharmacist prescribing. This study aimed to determine pharmacists' acceptance of a...
3.
McGregor A, Hoque M, Nickel S, Smith A, Atiquzzaman M
Drugs Real World Outcomes
. 2021 Sep;
9(1):165-173.
PMID: 34580835
Background: Patients who develop seizures after stroke have disproportionately poorer outcomes and increased mortality. Objective: Our objective was to investigate whether exposure to anti-epileptic medications influenced long-term functional status after...
4.
Leitch S, Dovey S, Cunningham W, Smith A, Zeng J, Reith D, et al.
Br J Gen Pract
. 2021 Apr;
71(709):e626-e633.
PMID: 33798090
Background: The extent of medication-related harm in general practice is unknown. Aim: To identify and describe all medication-related harm in electronic general practice records. The secondary aim was to investigate...
5.
Broughton L, Medlicott N, Smith A
Arch Womens Ment Health
. 2021 Mar;
24(4):569-578.
PMID: 33751206
Women face complicated decisions regarding psychotropic medication use during pregnancy. Patient decision aids (PDAs) could be a valuable tool to assist with decision-making. The objective of this review was to...
6.
Nair S, Chen S, Gupta D, Smith A, McGregor A
J Stroke Cerebrovasc Dis
. 2021 Mar;
30(5):105711.
PMID: 33714074
Objective: Obesity is a risk factor for ischaemic stroke but provides a survival advantage. The relationship between body mass index (BMI) and long-term function is less clear. The presence of...
7.
Smith A, Wilby K
J Prim Health Care
. 2020 Dec;
12(4):335-344.
PMID: 33349321
INTRODUCTION Sexually transmitted infection (STI) rates continue to rise in New Zealand. To effectively prevent, test and diagnose STIs in a timely manner to limit their health effects, health services...
8.
Simpson B, Reith D, Medlicott N, Smith A
J Prim Health Care
. 2020 Dec;
12(4):327-334.
PMID: 33349320
INTRODUCTION Dabigatran etexilate has become widely used in New Zealand, but information relating to when renal function monitoring is being undertaken is lacking. AIM To investigate if clinically appropriate renal...
9.
Wilby K, De Chun L, Ye R, Smith A
Acad Med
. 2020 Oct;
96(1):e4-e5.
PMID: 33031112
No abstract available.
10.
Burmeister P, Su S, Smith A, Wilby K
Ann Pharmacother
. 2020 May;
54(10):1030-1037.
PMID: 32436729
Objective: To evaluate clinical efficacy data for gentamicin in the treatment of gonorrhea. Data Sources: A keyword search of PubMed (1966 to April 2020), EMBASE (1947 to April 2020), and...